These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 3098573)

  • 1. Evidence for serotonin-S2 receptor involvement in analgesia in humans.
    Sandrini G; Alfonsi E; De Rysky C; Marini S; Facchinetti F; Nappi G
    Eur J Pharmacol; 1986 Nov; 130(3):311-4. PubMed ID: 3098573
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Electrophysiological evidence for a possible serotonergic involvement in some endogenous opiate activity in humans.
    Willer JC; Roby A; Gerard A; Maulet C
    Eur J Pharmacol; 1982 Feb; 78(1):117-20. PubMed ID: 7075659
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Differential regulation of dopamine-D2 and serotonin-S2 receptors by chronic treatment with the serotonin-S2 antagonists, ritanserin, and setoperone.
    Leysen JE; van Gompel P; Gommeren W; Laduron PM
    Psychopharmacol Ser; 1987; 3():214-24. PubMed ID: 2950521
    [No Abstract]   [Full Text] [Related]  

  • 4. Enhancement and depression of spinal reflexes by 8-hydroxy-2-(di-n-propylamino)tetralin in the decerebrated and spinalized rabbit: involvement of 5-HT1A- and non-5-HT1A-receptors.
    Clarke RW; Ogilvie J; Houghton AK
    Br J Pharmacol; 1997 Oct; 122(4):631-8. PubMed ID: 9375958
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Serotonin S2 receptors blockage and generalized anxiety disorders. A double-blind study on ritanserin and lorazepam.
    Bressa GM; Marini S; Gregori S
    Int J Clin Pharmacol Res; 1987; 7(2):111-9. PubMed ID: 3108171
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Electrical stimulation of the gastrocnemius muscle in the spontaneously hypertensive rat increases the pain threshold: role of different serotonergic receptors.
    Hoffmann P; Skarphedinsson JO; Delle M; Thorén P
    Acta Physiol Scand; 1990 Feb; 138(2):125-31. PubMed ID: 2138403
    [TBL] [Abstract][Full Text] [Related]  

  • 7. 5-HT2 receptor antagonism in dysthymic disorder: a double-blind placebo-controlled study with ritanserin.
    Bersani G; Pozzi F; Marini S; Grispini A; Pasini A; Ciani N
    Acta Psychiatr Scand; 1991 Apr; 83(4):244-8. PubMed ID: 1903019
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Attenuation of morphine analgesia by the S2 antagonists, pirenperone and ketanserin.
    Paul D; Mana MJ; Pfaus JG; Pinel JP
    Pharmacol Biochem Behav; 1988 Nov; 31(3):641-7. PubMed ID: 3251248
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ritanserin antagonism of m-chlorophenylpiperazine effects in neuroleptic-free schizophrenics patients: support for serotonin-2 receptor modulation of schizophrenia symptoms.
    Abi-Saab W; Seibyl JP; D'Souza DC; Karper LP; Gueorgueva R; Abi-Dargham A; Wong ML; Rajhans S; Erdos JP; Heninger GR; Charney DS; Krystal JH
    Psychopharmacology (Berl); 2002 Jun; 162(1):55-62. PubMed ID: 12107618
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The influence of ritanserin, a serotonin antagonist, in anxiety disorders: a double-blind placebo-controlled study versus lorazepam.
    Ceulemans DL; Hoppenbrouwers ML; Gelders YG; Reyntjens AJ
    Pharmacopsychiatry; 1985 Sep; 18(5):303-5. PubMed ID: 3931107
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dose-related effects of selective 5-HT2 receptor antagonists on slow wave sleep in humans.
    Sharpley AL; Solomon RA; Fernando AI; da Roza Davis JM; Cowen PJ
    Psychopharmacology (Berl); 1990; 101(4):568-9. PubMed ID: 2117764
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Action of serotonin in the medial prefrontal cortex: mediation by serotonin3-like receptors.
    Ashby CR; Edwards E; Wang RY
    Synapse; 1992 Jan; 10(1):7-15. PubMed ID: 1536032
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Receptor-binding properties in vitro and in vivo of ritanserin: A very potent and long acting serotonin-S2 antagonist.
    Leysen JE; Gommeren W; Van Gompel P; Wynants J; Janssen PF; Laduron PM
    Mol Pharmacol; 1985 Jun; 27(6):600-11. PubMed ID: 2860558
    [TBL] [Abstract][Full Text] [Related]  

  • 14. 5-Hydroxytryptamine-2 antagonist increases human slow wave sleep.
    Idzikowski C; Mills FJ; Glennard R
    Brain Res; 1986 Jul; 378(1):164-8. PubMed ID: 3091188
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effects of the 5 HT2 antagonist ritanserin on blood pressure and serotonin-induced platelet aggregation in patients with untreated essential hypertension.
    Stott DJ; Saniabadi AR; Hosie J; Lowe GD; Ball SG
    Eur J Clin Pharmacol; 1988; 35(2):123-9. PubMed ID: 3142775
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Objective assessment of clonidine analgesia in man and influence of naloxone.
    Porchet HC; Piletta P; Dayer P
    Life Sci; 1990; 46(14):991-8. PubMed ID: 2182959
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Serotonin receptors in the rat nucleus tractus solitarii and cardiovascular regulation.
    Shvaloff A; Laguzzi R
    Eur J Pharmacol; 1986 Dec; 132(2-3):283-8. PubMed ID: 3102261
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evidence for separate receptors that mediate parallel effects of serotonin and small cardioactive peptideB (SCPB) on adenylate cyclase in Aplysia californica.
    Ocorr KA; Byrne JH
    Neurosci Lett; 1986 Oct; 70(2):283-8. PubMed ID: 3095711
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ritanserin, a 5-HT2 receptor antagonist, does not modify ECT-induced prolactin release.
    Papakostas Y; Markianos M; Papadimitriou G; Stefanis C
    Psychopharmacology (Berl); 1990; 100(2):206-8. PubMed ID: 2106150
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of ritanserin on aversive classical conditioning in humans.
    Hensman R; Guimarães FS; Wang M; Deakin JF
    Psychopharmacology (Berl); 1991; 104(2):220-4. PubMed ID: 1908584
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.